Mezlocillin single-dose prophylaxis in biliary tract surgery. 1983

R Elke, and M Widmer, and H Gerber, and M Trippel, and U F Gruber

A prospective, controlled, double-blind, randomized multicenter trial including 12 Swiss hospitals with 358 patients was carried out. The aim of the study was to investigate whether a single-dose prophylaxis with 5 g mezlocillin given immediately before surgery can reduce not only the incidence of wound infections but other bacterial complications as well. Of the 324 correct protocols, 165 belonged to the placebo and 159 to the mezlocillin group. The two groups are comparable in all regards. The incidence of wound infections was 10% in the control and 4% in the treated group (p less than 0.05). The number of other infectious complications could not be reduced. No side effects due to the prevention were observed. Single-dose prevention with mezlocillin is proposed for all patients undergoing biliary tract surgery.

UI MeSH Term Description Entries
D008297 Male Males
D008802 Mezlocillin Semisynthetic ampicillin-derived acylureido penicillin. It has been proposed for infections with certain anaerobes and may be useful in inner ear, bile, and CNS infections. Bay-f 1353,Baypen,Melocin,Meslocillin,Mezlin,Mezlocillin Sodium,Mezlocilline,Bay f 1353,Bayf 1353,Sodium, Mezlocillin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011292 Premedication Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION. Premedications
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females

Related Publications

R Elke, and M Widmer, and H Gerber, and M Trippel, and U F Gruber
May 1978, Journal of the Royal College of Surgeons of Edinburgh,
R Elke, and M Widmer, and H Gerber, and M Trippel, and U F Gruber
April 1995, Minerva medica,
R Elke, and M Widmer, and H Gerber, and M Trippel, and U F Gruber
January 1985, Clinical therapeutics,
R Elke, and M Widmer, and H Gerber, and M Trippel, and U F Gruber
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
R Elke, and M Widmer, and H Gerber, and M Trippel, and U F Gruber
August 1988, The Journal of hospital infection,
R Elke, and M Widmer, and H Gerber, and M Trippel, and U F Gruber
November 1993, Israel journal of medical sciences,
R Elke, and M Widmer, and H Gerber, and M Trippel, and U F Gruber
July 1989, Journal of chemotherapy (Florence, Italy),
R Elke, and M Widmer, and H Gerber, and M Trippel, and U F Gruber
January 1986, Chemotherapy,
R Elke, and M Widmer, and H Gerber, and M Trippel, and U F Gruber
February 1994, The Journal of antimicrobial chemotherapy,
R Elke, and M Widmer, and H Gerber, and M Trippel, and U F Gruber
August 1987, Archives of surgery (Chicago, Ill. : 1960),
Copied contents to your clipboard!